STAAR Surgical Company (STAA)

Market Cap	831.85M
Revenue (ttm)	313.90M
Net Income (ttm)	-20.21M
Shares Out	49.31M
EPS (ttm)	-0.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,175,260
Open	17.14
Previous Close	16.85
Day's Range	16.75 - 17.49
52-Week Range	13.50 - 52.68
Beta	0.63
Analysts	Buy
Price Target	38.83 (+130.17%)
Earnings Date	Feb 11, 2025

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are prima...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1982
• Employees: 1,057
• Stock Exchange: NASDAQ
• Ticker Symbol: STAA
• Website: https://www.staar.com

Analyst Forecast

According to 8 analysts, the average rating for STAA stock is "Buy." The 12-month stock price forecast is $38.83, which is an increase of 130.17% from the latest price.

Price Target

$38.83

(130.17% upside)

Analyst Consensus: Buy